Emcure Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE168P01015
  • NSEID: EMCURE
  • BSEID: 544210
INR
1,641.60
-21.3 (-1.28%)
BSENSE

May 08

BSE+NSE Vol: 3.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
2,469.70
2,363.48
2,269.82
2,100.54
2,116.25
1,962.63
2,001.98
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,469.70
2,363.48
2,269.82
2,100.54
2,116.25
1,962.63
2,001.98
Raw Material Cost
418.58
421.23
420.46
432.50
403.87
399.83
391.49
Purchase of Finished goods
661.49
560.11
625.17
550.48
571.86
428.93
502.30
(Increase) / Decrease In Stocks
-34.11
-18.91
-156.10
-180.97
-83.62
-46.03
-105.12
Employee Cost
386.78
387.33
384.62
393.47
373.37
366.93
355.59
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
557.42
520.97
520.20
488.28
448.36
458.36
476.85
Total Expenditure (Excl Depreciation)
1,990.15
1,870.73
1,794.35
1,683.76
1,713.84
1,608.02
1,621.11
Operating Profit (PBDIT) excl Other Income
479.55
492.75
475.47
416.78
402.41
354.61
380.87
Other Income
3.99
1.85
3.12
3.70
4.45
3.90
35.65
Operating Profit (PBDIT)
483.54
494.60
478.59
420.48
406.86
358.51
416.52
Interest
46.40
37.98
32.54
26.76
39.03
31.78
46.22
Exceptional Items
10.30
-38.15
0.00
-3.50
-10.38
0.00
0.00
Gross Profit (PBDT)
447.44
418.47
446.05
390.22
357.45
326.73
370.30
Depreciation
106.27
104.68
104.64
99.46
96.84
96.81
96.90
Profit Before Tax
341.18
313.79
341.42
290.76
260.61
229.92
273.41
Tax
97.44
82.42
90.05
75.97
63.38
73.83
71.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
243.74
231.37
251.37
214.79
197.24
156.09
201.55
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
243.74
231.37
251.37
214.79
197.24
156.09
201.55
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.33
0.83
7.91
7.84
8.28
2.37
6.98
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
243.40
230.54
243.46
206.95
188.96
153.72
194.57
Equity Capital
189.57
189.57
189.57
189.51
189.48
189.43
189.10
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
12.84
12.16
12.84
10.92
9.97
8.11
10.29
Diluted Earnings per share
12.84
12.16
12.85
10.92
9.97
8.12
10.23
Operating Profit Margin (Excl OI)
19.42%
20.85%
20.95%
19.84%
19.02%
18.07%
19.02%
Gross Profit Margin
18.12%
17.71%
19.65%
18.58%
16.89%
16.65%
18.5%
PAT Margin
9.87%
9.79%
11.07%
10.23%
9.32%
7.95%
10.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 4.49% vs 4.13% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 5.58% vs -5.31% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -2.68% vs 3.63% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 22.17% vs 16.72% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Emcure Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,469.70
1,064.72
1,404.98
131.96%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,469.70
1,064.72
1,404.98
131.96%
Raw Material Cost
418.58
212.01
206.57
97.43%
Purchase of Finished goods
661.49
104.34
557.15
533.98%
(Increase) / Decrease In Stocks
-34.11
13.08
-47.19
-360.78%
Employee Cost
386.78
191.42
195.36
102.06%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
557.42
248.05
309.37
124.72%
Total Expenditure (Excl Depreciation)
1,990.15
768.90
1,221.25
158.83%
Operating Profit (PBDIT) excl Other Income
479.55
295.82
183.73
62.11%
Other Income
3.99
18.28
-14.29
-78.17%
Operating Profit (PBDIT)
483.54
314.10
169.44
53.94%
Interest
46.40
1.88
44.52
2,368.09%
Exceptional Items
10.30
0.00
10.30
Gross Profit (PBDT)
447.44
312.22
135.22
43.31%
Depreciation
106.27
45.35
60.92
134.33%
Profit Before Tax
341.18
266.87
74.31
27.85%
Tax
97.44
68.98
28.46
41.26%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
243.74
197.89
45.85
23.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
243.74
197.89
45.85
23.17%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.33
0.00
0.33
Other related items
0.00
0.00
0.00
Consolidated Net Profit
243.40
197.89
45.51
23.00%
Equity Capital
189.57
15.67
173.90
1,109.76%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.84
12.63
0.21
1.66%
Diluted Earnings per share
12.84
12.45
0.39
3.13%
Operating Profit Margin (Excl OI)
19.42%
27.78%
0.00
-8.36%
Gross Profit Margin
18.12%
29.32%
0.00
-11.20%
PAT Margin
9.87%
18.59%
0.00
-8.72%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,469.70 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 4.49% vs 4.13% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 16.70% vs 19.47% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 243.40 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 5.58% vs -5.31% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 28.81% vs 64.07% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 479.55 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.68% vs 3.63% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 19.17% vs 29.25% in Mar 2025

Quarterly - Interest
Interest 46.40 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 22.17% vs 16.72% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 18.88% vs -40.40% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.42%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025